Marc Baumann

Marc Baumann serves as a Docent (equivalent to Associate Professor) at the University of Helsinki within the Medicum faculty and Department of Biochemistry and Developmental Biology. He acts as a Supervisor in the Doctoral Programme in Integrative Life Science and the Doctoral Programme Brain & Mind, demonstrating his active role in graduate education and research mentorship at one of Europe's leading research universities.

Dr. Baumann's research spans multiple critical areas of biomedical science, with primary focus on proteomics, mass spectrometry applications, and biochemical mechanisms underlying disease processes. His work bridges basic science and clinical applications, particularly in neurodegenerative disorders and cardiovascular disease. He has established himself as a specialist in advanced proteomic techniques for analyzing protein modifications and interactions.

Analysis of his publication record reveals a strong emphasis on developing and applying cutting-edge proteomic methodologies. His recent work demonstrates expertise in thermal proteome profiling, MALDI-MS applications, and analysis of posttranslational modifications. The research consistently connects molecular mechanisms to disease pathology, particularly in Alzheimer's disease (amyloid-β studies) and atherosclerosis. His collaborative approach is evident through numerous co-authorships across multiple institutions.

Dr. Baumann actively participates in significant research projects, including the CIHR-funded LALOWSKI project (2023-2026) where he serves as Principal Investigator. He has also contributed to the Digital Leap project focused on e-assessment in medical education and the CADASIL disease research in Finland. His work has received media attention, particularly regarding mass spectrometry equipment and research on menopause, estrogen, and muscle function.

His laboratory work appears centered around advanced mass spectrometry techniques, with specific mention of SIM/MRM mass spectrometry equipment. The research group likely focuses on proteomic analysis of biological samples, with applications in neurodegenerative disease, cardiovascular pathology, and drug mechanism studies. His collaborations with researchers like Lalowski, Soliymani, and others suggest an interdisciplinary team approach to complex biomedical questions.